SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS

Documenti analoghi

• RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease.
  di: de Wit, J, et al.
  Pubblicazione: (2015)
• Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
  di: Jiuping Zeng, et al.
  Pubblicazione: (2023-06-01)
• BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
  di: Hammitzsch, A, et al.
  Pubblicazione: (2014)
• Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
  di: Steven A Saenz, et al.
  Pubblicazione: (2021-01-01)
• Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo
  di: Steven A. Saenz, et al.
  Pubblicazione: (2021-01-01)